ECOR1 CAPITAL, LLC
Adviser information for ECOR1 CAPITAL, LLC last updated from Form ADV on March 28th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
Type of Organization | Limited Liability Company |
---|---|
Fiscal Year End | DECEMBER |
Legal Location | Delaware, United States |
Employees
Total Number of Employees | 21 |
---|---|
Investment Advisory/Research | 8 |
Registered Broker-Dealer Representatives | 0 |
Registered State Investment Advisers | 0 |
Licensed Agents of an Insurance Company | 0 |
No. of Firms/People that Solicit Clients | 0 |
RAUM
Provides Management of Securities Portfolios | Yes |
---|
Type | Accounts | RAUM |
---|---|---|
Discretionary | 5 | $5.0B |
Non-Discretionary | 0 | $0 |
Total | 5 | $5.0B |
Clients
Type | Number | RAUM |
---|---|---|
Individuals | 0 | $0 |
HNW Individuals | 0 | $0 |
Banking or thrift institutions | 0 | $0 |
Investment companies | 0 | $0 |
Business development companies | 0 | $0 |
Pooled investment vehicles | 5 | $5.0B |
Pension and profit sharing plans | 0 | $0 |
Charitable organizations | 0 | $0 |
State or municipal gov entities | 0 | $0 |
Other investment advisers | 0 | $0 |
Insurance companies | 0 | $0 |
Sovereign wealth funds and foreign official institutions | 0 | $0 |
Corporations or other businesses | 0 | $0 |
Other | 0 | $0 |
Type | Number |
---|---|
No. of Non-RAUM Clients | 0 |
No. of Non-U.S. Clients | 40 |
Services
Advisory Services | Portfolio management for pooled investment vehicles |
---|---|
Compensation | % of AUMPerformance-based fees |
Other Business Activities | Commodity pool operator or commodity trading advisor |
Principal Office
357 TEHAMA STREETFLOOR 3
SAN FRANCISCO
CA
United States
Monday - Friday, 8:00AM - 2:00PM
Tel: 415-754-3517, Fax: 415-952-9412
Chief Compliance Officer
SARAH MARRIOTT
COO, CCO
357 TEHAMA STREET
FLOOR 3
SAN FRANCISCO
CA
United States
Tel:
415-754-3517
Fax:
415-952-9412
S****@***********M
(Full email address available in API data)
Regulatory Contact
N/A
N/A
N/A
N/A
Other
Industry Affiliates
BIOTECH OPPORTUNITY GP, LLC | Sponsor, GP, manager of pooled investment vehicles |
Private Funds
Name | Type | Assets $USD | Min Investment $USD | No. Owners |
---|---|---|---|---|
ECOR1 CAPITAL FUND QUALIFIED, L.P. | Hedge Fund | $4,604.5M | $25.0M | 324 |
ECOR1 CAPITAL FUND, L.P. | Hedge Fund | $311.9M | $25.0M | 87 |
ECOR1 VENTURE OPPORTUNITY FUND, LP | Venture Capital Fund | $85.3M | $2.0M | 59 |
Control Persons
Name | Type | Entity | Title | Since | Ownership |
---|---|---|---|---|---|
NODELMAN, TRUSTEE, OLEG | Individual | – | MANAGER | 11/2012 | > 75% |
MARRIOTT, TRUSTEE, SARAH | Individual | – | MEMBER, CCO, COO | 11/2012 | 10-25% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name | Class | Value $USD | # Shares | Private Fund |
---|---|---|---|---|
ACADIA PHARMACEUTICALS INC | COM | 22M | 1M | – |
ADAPTIMMUNE THERAPEUTICS PLC | SPONDS ADR | 27M | 27M | – |
ALIGOS THERAPEUTICS INC | COM | 2M | 6M | – |
ALLOVIR INC | COM | 8M | 11M | – |
ANAPTYSBIO INC | COM | 188M | 8M | – |
APELLIS PHARMACEUTICALS INC | COM | 445M | 12M | – |
ARVINAS INC | COM | 179M | 7M | – |
ATARA BIOTHERAPEUTICS INC | COM NEW ADDED | 3M | 407K | – |
ATEA PHARMACEUTICALS INC | COM | 18M | 5M | – |
AVIDITY BIOSCIENCES INC | COM | 31M | 758K | – |
BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 18M | 910K | – |
CAREMAX INC | *W EXP 06/08/202 | 279K | 100K | – |
CARGO THERAPEUTICS INC | COM | 24M | 1M | – |
CELLDEX THERAPEUTICS INC | COM NEW | 24M | 650K | – |
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 52M | 6M | – |
CRINETICS PHARMACEUTICALS IN | COM | 186M | 4M | – |
CRISPR THERAPEUTICS AG | NAMEN AKT | 75M | 1M | – |
DYNE THERAPEUTICS INC | COM | 15M | 427K | – |
EDGEWISE THERAPEUTICS INC | COM | 23M | 1M | – |
GALAPAGOS NV | SPON ADR | 143M | 6M | – |
GENERATION BIO CO | COM | 6M | 2M | – |
HOOKIPA PHARMA INC | COM | 3M | 6M | – |
IMMUNOME INC | COM | 47M | 4M | – |
ITEOS THERAPEUTICS INC | COM | 48M | 3M | – |
JANUX THERAPEUTICS INC | COM | 62M | 1M | – |
JAZZ PHARMACEUTICALS PLC | SHS USD | 108M | 1M | – |
KEROS THERAPEUTICS INC | COM | 9M | 188K | – |
KURA ONCOLOGY INC | COM | 120M | 6M | – |
KYVERNA THERAPEUTICS INC | COM | 3M | 450K | – |
LENZ THERAPEUTICS INC | COM | 21M | 1M | – |
MADRIGAL PHARMACEUTICALS INC | COM | 21M | 75K | – |
MERSANA THERAPEUTICS INC | COM | 39M | 19M | – |
MORPHIC HLDG INC | COM | 170M | 5M | – |
NEUMORA THERAPEUTICS INC. | COM | 20M | 2M | – |
NEUROGENE INC | COM | 46M | 1M | – |
NUVATION BIO INC | *W EXP 07/07/202 | 3M | 963K | – |
NUVATION BIO INC | COM CL A | 56M | 19M | – |
ORIC PHARMACEUTICALS INC | COM | 24M | 3M | – |
PHARVARIS N V | COM | 17M | 900K | – |
PRIME MEDICINE INC | COM | 4M | 700K | – |
PROQR THRAPEUTICS N V | SHS EURO | 3M | 2M | – |
PROTHENA CORP PLC | SHS | 239M | 12M | – |
REPLIMUNE GROUP INC | COM | 8M | 850K | – |
ROCKET PHARMACEUTICALS INC | COM | 11M | 508K | – |
SAREPTA THERAPEUTICS INC | COM | 222M | 1M | – |
SURROZEN INC | *W EXP 08/01/203 | 730K | 67K | – |
TANGO THERAPEUTICS INC | COM | 114M | 13M | – |
TECTONIC THERAPEUTIC INC | COM ADDED | 14M | 849K | – |
THIRD HARMONIC BIO INC | COM | 41M | 3M | – |
TSCAN THERAPEUTICS INC | COM | 29M | 5M | – |
VAXCYTE INC | COM | 23M | 300K | – |
VERVE THERAPEUTICS INC | COM | 6M | 1M | – |
VOYAGER THERAPEUTICS INC | COM | 31M | 4M | – |
XENCOR INC | COM | 101M | 5M | – |
ZYMEWORKS INC | COM | 114M | 13M | – |